Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
7
Number of overlapping holdings
28.0%
% of BBH's 27 holdings also in IDNA
14.9%
% of IDNA's 51 holdings also in BBH
Overlap by Weight
Sector Drift (BBH minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in BBH |
Weight in IDNA |
Overlap | |
---|---|---|---|---|
MODERNA, INC. | 5.6% | 5.0% | 5.0% | |
REGENERON PHARMACEUTICALS | 7.9% | 4.3% | 4.3% | |
GILEAD SCIENCES INC | 8.0% | 3.4% | 3.4% | |
SAREPTA THERAPEUTICS INC | 2.4% | 5.3% | 2.4% | |
BIONTECH SE SPONSORED ADR | 2.2% | 3.4% | 2.2% |
Position Highlights (Non-Overlapping Exposures)
BBH Overweight Relative to IDNA
AMGEN INC | 15.3% | |
VERTEX PHARMACEUTICALS INC | 9.7% | |
IQVIA HOLDINGS INC | 4.9% | |
GILEAD SCIENCES INC | 4.7% | |
ARGENX SE ADR | 4.4% | |
BIOGEN IDEC INC | 4.3% | |
ILLUMINA INC | 4.2% | |
ICON PLC | 4.2% | |
REGENERON PHARMACEUTICALS | 3.6% | |
BIOMARIN PHARMACEUTICAL INC | 3.1% |
BBH Underweight Relative to IDNA
REVOLUTION MEDICINES, INC. | -5.6% | |
MERCK & CO. INC. | -4.7% | |
EXELIXIS INC | -4.0% | |
SANOFI-AVENTIS | -3.9% | |
TAKEDA PHARMACEUTICAL CO LTD | -3.6% | |
GENMAB A/S | -3.6% | |
ROCHE HOLDING LTD | -3.5% | |
BEIGENE, LTD. | -3.1% | |
IOVANCE BIOTHERAPEUTICS INC | -3.0% | |
SAREPTA THERAPEUTICS INC | -3.0% |